U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2024
711
Name Type Language
Zenocutuzumab
USAN   INN  
Official Name English
MCLA-128
Preferred Name English
ZENOCUTUZUMAB [USAN]
Common Name English
MCLA128
Code English
Immunoglobulin G1, bispecific, anti-(human epidermal growth factor receptors, HER2 and HER3) (humanized clone MCLA-128 ?1-chain), disulfide with humanized clone MCLA-128 light chain, dimer
Common Name English
Zenocutuzumab [WHO-DD]
Common Name English
Immunoglobulin G1-kappa, anti-(Homo sapiens Receptor tyrosine-protein kinase erbB-3 (Proto-oncogene-like protein c-ErbB-3, Tyrosine kinase-type cell surface receptor HER3, EC=2.7.10.1)) and anti-(Homo sapiens Receptor tyrosine-protein kinase erbB-2 (Meta
Common Name English
MCLA-128 (IGG1 BISPECIFIC ANTIBODY WITH ENHANCED ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY (ADCC) ACTIVITY TARGETING HER2 AND HER3 RECEPTORS.)
Common Name English
zenocutuzumab [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 750020
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
NCI_THESAURUS C129822
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
Code System Code Type Description
CAS
1969309-56-5
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
PRIMARY
NCI_THESAURUS
C152948
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
PRIMARY
DRUG BANK
DB15559
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
PRIMARY
USAN
HI-231
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
PRIMARY
SMS_ID
300000025314
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
PRIMARY
FDA UNII
AE72RB1W1X
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
PRIMARY
INN
10687
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
PRIMARY
ACTIVE MOIETY
Zenocutuzumab
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966